Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
7 Hills Pharma logo — First-in-concept platform of oral drugs to overcome immunoth...

7 Hills Pharma

First-in-concept platform of oral drugs to overcome immunotherapy resistance

Founded 1995 United States Houston, United States 12 employees Grant Total: $23.20M Health Care, Pharmaceutical

General Information

Company Name 7 Hills Pharma
Founded Year 1995
Location United States Houston, United States
Founders / Decision Makers
Team member Team member
Employees 12
Industries Health Care, Pharmaceutical
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with 7 Hills Pharma. To contact 7 Hills Pharma, visit 7hillspharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does 7 Hills Pharma compare?

A PDF of 7 Hills Pharma and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting 7 Hills Pharma soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About 7 Hills Pharma

7 Hills Pharma is a clinical-stage pharmaceutical company founded in 1995, with a focus on developing first-in-concept, oral immune stimulants to augment a broad range of immunotherapies for the treatment of drug-resistant solid tumors and prevention of infectious diseases. The company's slogan, "First-in-concept platform of oral drugs to overcome immunotherapy resistance," encapsulates its mission. Their compounds, which are selective, allosteric, systemic activators of the integrins LFA-1 and VLA-4, have demonstrated the potential to enhance the effectiveness of prophylactic vaccines for influenza, COVID-19, Tuberculosis, and Chagas disease, as well as checkpoint inhibitors for solid tumors. Their lead molecule, 7HP349, has completed a Phase I first-in-human clinical trial, showcasing oral bioavailability, exceptional safety profile, and efficacy at therapeutic levels. The latest investment of $4.70M as a grant was received on 03 June 2024 from the Cancer Prevention and Research Institute of Texas. With a focus on Health Care and Pharmaceutical industries, 7 Hills Pharma is well-positioned to make significant strides in the field of immunotherapy and infectious disease prevention.

Business keywords: Immunotherapy, Pharmaceuticals, Drug development, Clinical-stage, Immuno-oncology, Oral drugs, Solid tumors, Immune stimulants, Allosteric activators, Integrin modulation, Preclinical models, Infectious diseases, Prophylactic vaccines, Checkpoint inhibitors, Cell therapy

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $4.70M 1
Cancer Prevention and Research Institute of Texas
03 Jun 2024
Grant $13.50M 1
Cancer Prevention and Research Institute of Texas
22 May 2023
Grant $3.00M 1
National Institute of Allergy and Infectious Diseases
01 Aug 2022
Grant $2.00M 1
National Institutes of Health
19 Jun 2018

7 Hills Pharma Alternatives & Competitors

View All Alternatives
7 Hills Pharma vs
Janux Therapeutics
Janux Therapeutics United States

Developing unique immunotherapies that generate tumor-specific immune responses to attack and kill t...

IPO
120 employees
Biotechnology, Health Care
7 Hills Pharma vs
iOmx Therapeutics AG
iOmx Therapeutics AG Germany

Developing next-generation targeted cancer immunotherapy treatments

Series B
50 employees
Biopharma, Health Care
7 Hills Pharma vs
OXFORD VACMEDIX UK LIMITED
OXFORD VACMEDIX UK LIMITED United Kingdom

Developing therapeutic cancer vaccines using ROP technology

Series A
8 employees
Health Care, Health and Wellness
View all alternatives

FAQ About 7 Hills Pharma

First-in-concept platform of oral drugs to overcome immunotherapy resistance
7 Hills Pharma was founded in 1995.
7 Hills Pharma is headquartered in Houston, United States.
7 Hills Pharma operates in Health Care and Pharmaceutical. Its work centres on Immunotherapy, Pharmaceuticals, Drug development and Clinical-stage.
7 Hills Pharma has approximately 12 employees.
7 Hills Pharma has completed 4 funding rounds, raising a total of $23.20M. The latest funding stage is Grant.
Top alternatives and competitors to 7 Hills Pharma include Janux Therapeutics, iOmx Therapeutics AG, OXFORD VACMEDIX UK LIMITED, Kiromic Biopharma, Inc., Affinivax Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
7 Hills Pharma and Janux Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for 7 Hills Pharma, https://bouncewatch.com/company/7-hills-pharma, updated 20 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout